Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,473
Recruiting: 1,285
Ph III recruiting: 130
Growth YoY: +6.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,641)

clinicaltrialsPublishedShowing 10,601–10,627 of 10,627 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00035022	Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas	completed	Phase 1 / Phase 2	71	BioCryst PharmaceuticalsINDUSTRY	1	Jan 13, 2006	clinicaltrials
NCT00188149	Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET	unknown	Phase 4	300	University Hospital Carl Gustav CarusOTHER	1	Dec 29, 2005	clinicaltrials